YF-VAX

This brand name is authorized in United States. It is also authorized in Canada.

Active ingredients

The drug YF-VAX contains one active pharmaceutical ingredient (API):

`1`	Yellow fever, live attenuated UNII `PY4EET359T` - YELLOW FEVER VIRUS STRAIN 17D-204 LIVE ANTIGEN
	Read more about Yellow fever, live attenuated

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
YF-VAX Powder for suspension	MPI, US: SPL/Old	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J07BL01	Yellow fever, live attenuated	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BL Yellow fever vaccines
Discover more medicines within J07BL01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00428833
US	FDA, National Drug Code	49281-915

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.